SHC — Sotera Health Company stock price and chart

SHC

$17.93+1.64%

as of close, Oct 20, 2026

☾ AH $17.93 +1.64%

Sotera Health CompanyStock · HealthcareNasdaq Composite · 0.01% of ONEQRussell 1000 · 0.007% of IWBUS Stock Market · 0.007% of VTIRussell 3000 · 0.006% of IWV

PeersCRLRVTYICLRMEDPSPYQQQ

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Nov 24, 2020

VolumeEEEEEEEEEEEE

20202022202320252026

8.010.012.014.016.018.020.022.024.026.028.0020.0M40.0M$17.93

2026-10-20

Price$17.93

MA20$18.56

MA50$17.06

Vol3.4M

What would $1,000 invested in SHC be worth today? →

SHC returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $17.93
YTD price return: +1.64%
YTD total return: +1.64%
Next earnings: Nov 3, 2026
Market cap: 5.1B2020-12 7.8B2026-10 5.1B-34.2% over the window
Enterprise value: 7B
Shares outstanding: 285.4M2019-12 232.4M2026-06 285.4M+22.8% over the window
52W low: $13.09
52W high: $19.85
From 52W high: -9.67%
From 52W low: +36.97%
52W range: 72%

Volume

Rel volume: 0.91×
30D volume: 2M
30D $ vol: 36.3M

Fundamentals

Sales (ttm): 1.2B2019-12 778.3M2026-06 1.2B+56.3% over the window
Sales/share: $4.262019-12 $3.352026-06 $4.26+27.2% over the window
EPS (ttm): $0.572019-12 -$0.092026-06 $0.57-731.7% over the window
FCF (ttm): 112.7M2019-12 91.8M2026-06 112.7M+22.8% over the window
FCF/share: $0.392019-12 $0.392026-06 $0.39-0.0% over the window
Book value/share: $2.332019-12 -$2.762026-06 $2.33-184.6% over the window
Net margin: 13.44%2019-12 -2.7%2026-06 13.4%-601.8% over the window
ROE: 24.56%2020-12 -8.5%2026-06 24.6%-387.7% over the window
ROA: 4.94%2020-12 -1.4%2026-06 4.9%-453.5% over the window
Debt / equity: 3.19×2020-12 4.032026-06 3.19-20.9% over the window
Current ratio: 2.802020-12 2.242026-06 2.80+24.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +8.15%2025-06-30 → 2026-06-301.1B → 1.2B (+8.1% total)+7.60%2023-06-30 → 2026-06-30976.2M → 1.2B (+24.6% total)+6.66%2021-06-30 → 2026-06-30880.9M → 1.2B (+38.1% total)n/a
Net income: +581.40%2025-06-30 → 2026-06-3024M → 163.5M (+580.5% total)n/a+75.69%2021-06-30 → 2026-06-309.8M → 163.5M (+1573.1% total)n/a
FCF: +0.00%2025-06-30 → 2026-06-30112.7M → 112.7M (+0.0% total)n/a-2.41%2021-06-30 → 2026-06-30127.3M → 112.7M (-11.5% total)n/a
Shares: +0.47%2025-06-30 → 2026-06-30284M → 285.4M (+0.5% total)+0.32%2023-06-30 → 2026-06-30282.6M → 285.4M (+1.0% total)+0.17%2021-06-30 → 2026-06-30282.9M → 285.4M (+0.9% total)n/a

Per-share growth (CAGR, ttm) · 10Y

EPS: +575.70%2025-06-30 → 2026-06-30$0.08 → $0.57 (+574.8% total)n/a+72.32%2021-06-30 → 2026-06-30$0.04 → $0.57 (+1418.9% total)n/a
Sales/share: +7.65%2025-06-30 → 2026-06-30$3.96 → $4.26 (+7.6% total)+7.25%2023-06-30 → 2026-06-30$3.45 → $4.26 (+23.4% total)+6.48%2021-06-30 → 2026-06-30$3.11 → $4.26 (+36.9% total)n/a
FCF/share: -0.46%2025-06-30 → 2026-06-30$0.40 → $0.39 (-0.5% total)n/a-2.57%2021-06-30 → 2026-06-30$0.45 → $0.39 (-12.2% total)n/a
Book value/share: +29.61%2025-06-30 → 2026-06-30$1.80 → $2.33 (+29.6% total)+16.36%2023-06-30 → 2026-06-30$1.48 → $2.33 (+57.6% total)+4.75%2021-06-30 → 2026-06-30$1.85 → $2.33 (+26.1% total)n/a
Price: +7.31%2025-10-20 → 2026-10-20$16.71 → $17.93 (+7.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+10.83%2023-10-20 → 2026-10-20$13.17 → $17.93 (+36.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-7.09%2021-10-20 → 2026-10-20$25.90 → $17.93 (-30.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +7.31%2025-10-20 → 2026-10-20$16.71 → $17.93 (+7.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+10.83%2023-10-20 → 2026-10-20$13.17 → $17.93 (+36.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-7.09%2021-10-20 → 2026-10-20$25.90 → $17.93 (-30.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 31.5×2020-12 -201.272026-10 31.30-115.6% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 17.2×2020-12 37.732026-10 17.19-54.4% over the window
Fwd P/E: 16.7×
P/S (ttm)Market cap ÷ TTM revenue.: 4.2×2020-12 9.502026-10 4.21-55.7% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 7.7×2020-12 17.182026-10 7.69-55.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 45.4×2020-12 115.872026-10 45.40-60.8% over the window
EV/EBITDA (fy): 17.9×
EV/Sales (ttm): 5.8×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 2.20%2020-12 0.9%2026-06 2.2%+157.8% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 285.4M ÷ 284.0M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.47%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.47%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($3.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -0.47%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($5.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2020-12 -14.4%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($5.1B). Same caveat as the cash buyback yield.: 0.00%2020-12 -14.4%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/E: 9th
P/OI: 50th
P/S: 48th
P/B: 21st
P/FCF: 47th

Bar = where today’s multiple sits in SHC’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+1.64%

-1.54%

-4.27%

+2.93%

YTD

+1.64%

+7.30%

-30.77%

Financial statements

Open full SHC financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

SHC — Sotera Health Company price, chart and key statistics